PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2019-10-09

Date Title Company
09-Oct-2019 Sedana Medical AB (publ) Intends to Undertake a Directed New Share Issue Sedana Medical
09-Oct-2019 Group Spearheads Event to Drive Therapies Aimed at Biggest Cause of Cancer Deaths Front Line Genomics
09-Oct-2019 RedHawk Completes a Limited Marketing Campaign and Announces Anticipated Interest INSANDD Mini(TM) Needle Incineration Units RedHawk Holdings Corp.
09-Oct-2019 Sirnaomics' President and CEO Patrick Lu to Give Keynote Address at RNAi China Conference Sirnaomics, Inc.
09-Oct-2019 TraceLink Announces New Digital Network Platform to Further Transform the Global Pharmaceutical Supply Chain TraceLink
09-Oct-2019 Amgen Foundation Launches Amgen Biotech Experience In Pittsburgh Amgen
09-Oct-2019 Companies Turn to Advanced Therapies to Curb the Spread of Cancer FinancialBuzz.com
09-Oct-2019 N-SIDE welcomes Wade Wirta as US Managing Director N-SIDE
09-Oct-2019 Nutrigenomics Market to Experience Robust Growth due to Rising Cases of Food Allergies Till 2025 | Million Insights Million Insights
09-Oct-2019 Datar Cancer Genetics Announces Positive Results With 42.9% Objective Response Rate, and 90.5% Disease Control Rate in Heavily Pre-treated Patients With Ultra-personalised Pan-cancer Treatment Protocol in the RESILIENT Trial Datar Cancer Genetics Ltd
09-Oct-2019 Datar Cancer Genetics Announces Positive Results With 42.9% Objective Response Rate, and 90.5% Disease Control Rate in Heavily Pre-treated Patients With Ultra-personalised Pan-cancer Treatment Protocol in the RESILIENT Trial Datar Cancer Genetics Ltd
09-Oct-2019 UCB showcases wealth of new psoriasis research at EADV 2019 UCB
09-Oct-2019 Creative Diagnostics Introduces New Portfolio of Phospho-specific Antibodies Creative Diagnostics
09-Oct-2019 AbbVie Announces New Data from its Dermatology Portfolio and Pipeline at the 28th European Academy of Dermatology and Venereology (EADV) Congress AbbVie
09-Oct-2019 EVOTEC AND CELMATIX ENTER INTO STRATEGIC COLLABORATION Evotec SE
09-Oct-2019 Tim Oldham Appointed as Chief Executive Officer of AdAlta Ltd AdAlta Limited